![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FIRM RECALLS ATTENTION-DEFICIT DRUG
FIRM RECALLS ATTENTION-DEFICIT DRUG
A pharmaceutical company has issued a nationwide recall of approximately 500 bottles of a drug used to treat attention-deficit/hyperactivity disorder and narcolepsy. One lot of Methylin chewable tablets in 5-mg strength may contain as much as three times the active ingredient, Alliant Pharmaceuticals said in a recent statement. The Alpharetta, Ga.-based company voluntarily recalled the drug after testing and evaluation. The company said that medication from the lot could pose serious health risk for some patients.
South Bend Tribune (http://www.southbendtribune.com/stories/2005/01/16/nation.20050116-sbt-MICH-A4-Firm_recalls_attenti.sto)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct